Question 1

What is the catalog number for Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued?

Accepted Answer

The catalog number for Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued is C9001-21.

Question 2

What sizes are available for Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued?

Accepted Answer

Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued is available in the following size(s): 50 µg.

Question 3

Is Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued in stock?

Accepted Answer

Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued is currently made to order / not held in immediate stock. Contact us for lead time.

Question 4

How long will it take to receive this product if it’s custom made?

Accepted Answer

Lead times depend on the product type: custom polyclonal antibodies typically take 12-14 weeks, monoclonal antibodies 15-17 weeks, made-to-order recombinant proteins 4-8 weeks, and made-to-order recombinant antibodies 6-8 weeks. These are estimates and may shift due to production delays.

Question 5

What is the recommended dilution for this antibody?

Accepted Answer

A recommended dilution range for each validated application is provided on the datasheet, but optimal dilution should be titrated for your specific experimental system, sample type, and detection method.

Question 6

What is the recommended storage temperature after reconstitution?

Accepted Answer

Post-reconstitution storage guidance is listed on the datasheet, typically requiring aliquoting and storage at -20°C or -80°C to preserve activity.

Cysteine and Glycine-rich Protein 3 (CSRP3) discontinued

Product Specifications

Clonality

Frequently Asked Questions

Explore Other Products

Lung Specific Antigen (LSA120), 0.2mg/mL

Cytokeratin 16 (KRT16) (Suprabasal Keratinocyte Marker) (LL025), CF640R conjugate, 0.1mg/mL

HSP60 (GROEL/730), CF647 conjugate, 0.1mg/mL

Nucleophosmin (Acute Myeloid Leukemia Marker) (NPM1/1902), 0.2mg/mL

NKX6.1 (Marker for Pancreatic and Duodenal Neuroendocrine Tumors) (NKX61/2561), CF647 conjugate, 0.1mg/mL

MyoD1 (Rhabdomyosarcoma Marker) (rMYD712), CF640R conjugate, 0.1mg/mL